2022
DOI: 10.1016/j.taap.2022.115990
|View full text |Cite
|
Sign up to set email alerts
|

Rac GTPases in acute myeloid leukemia cells: Expression profile and biological effects of pharmacological inhibition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 72 publications
1
5
0
Order By: Relevance
“…Compared with normal tissues, Rac3 mRNA levels were significantly overexpressed in BLCA, CESC, DLBC, HNSC, LIHC, LUAD, LUSC, OV, PAAD, PRAD, SKCM, THCA, THYM, UCEC, and UCS, while it was underexpressed in KIRC and LAML. The results were further supported by previous studies involving in bladder cancer [10], [11], lung adenocarcinoma [14], [38], breast cancer [39], [40], prostate carcinomas [41], brain tumors [42], colitis-associated cancer [43], and acute myeloid leukemia [44]. Moreover, the protein expression of Rac3 was highly expressed in lung cancer, head and neck cancer, liver cancer, urothelial cancer, breast cancer, cervical cancer, ovarian cancer, lymphoma, and skin cancer from the HPA database.…”
Section: Discussionsupporting
confidence: 86%
See 2 more Smart Citations
“…Compared with normal tissues, Rac3 mRNA levels were significantly overexpressed in BLCA, CESC, DLBC, HNSC, LIHC, LUAD, LUSC, OV, PAAD, PRAD, SKCM, THCA, THYM, UCEC, and UCS, while it was underexpressed in KIRC and LAML. The results were further supported by previous studies involving in bladder cancer [10], [11], lung adenocarcinoma [14], [38], breast cancer [39], [40], prostate carcinomas [41], brain tumors [42], colitis-associated cancer [43], and acute myeloid leukemia [44]. Moreover, the protein expression of Rac3 was highly expressed in lung cancer, head and neck cancer, liver cancer, urothelial cancer, breast cancer, cervical cancer, ovarian cancer, lymphoma, and skin cancer from the HPA database.…”
Section: Discussionsupporting
confidence: 86%
“…Recent studies revealed that Rac3 was overexpressed by confirmed with qRT-PCR and western blot results and indicated a poor prognosis in bladder cancer [10], [45]. Ramos et al revealed that Rac3 levels were increased in AML compared with healthy donors [44]. Rac3 was overexpressed and associated with more prolonged survival in LUAD patients [38], [46].…”
Section: Discussionmentioning
confidence: 88%
See 1 more Smart Citation
“… 33 , 49 , 50 This process-dependent variability is also exemplified by cell death. While significant increases in apoptotic OCI-AML3 human acute myeloid leukemia and bladder smooth muscle cells were observed after treatment with 30 μM and 50 μM EHT1864, respectively, 51 , 52 rat HBCs in vehicle- and 50 μM EHT1864-treated cultures demonstrated similar morphological appearances ( Figures 4 A–4D, 4F, and 4I) and treated mouse platelets retained significant viability up to 200 μM EHT1864. 53 …”
Section: Discussionmentioning
confidence: 90%
“…Early research indicated that inactivation of RAC1-GTPase suppressed migration and promoted drug induced apoptosis in KG-1 cells ( 37 ). Recent in vitro studies found that suppression of RAC with a RAC inhibitor (EHT-1864) could increase autophagy, apoptosis, cell cycle, modulation of p53 factor and inhibit the PI3K/AKT/mTOR signaling pathway in AML cell lines ( 38 ). In fact, it has recently been reported that the combination of EHT-1846, venetoclax(BCL-2 inhibitor) and midostaurin(FLT3 inhibitor) could reverse midostaurin resistance in AML cells ( 39 ).…”
Section: Discussionmentioning
confidence: 99%